Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for breast cancer screening
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on breast cancer screening or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on breast cancer screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via firstname.lastname@example.org
BreastCancerScreening Options for Women with Dense Breast Tissue Proven Best Choices: BreastCancerScreening – ICER Menu Close Other ICER Proven Best Choices: BreastCancerScreening A patient guide for choosing supplemental breastcancerscreening options for women with dense breasts. or EMAIL SIGNUP Stay up-to-date on the latest news from ICER. CONTACT US Institute for Clinical and Economic Review Two Liberty Square, Ninth Floor, Boston, MA 02109 (617) 528-4013 STAY CONNECTED |
Ultrasound as an Adjunct to Mammography for BreastCancerScreening Health Quality Ontario The provincial advisor on the quality of health care in Ontario Let’s make our health system healthier Ultrasound as an Adjunct to Mammography for BreastCancerScreening: OHTAC Recommendation ONTARIO HEALTH TECHNOLOGY ADVISORY COMMITTEE RECOMMENDATIONS ? The Ontario Health Technology Advisory Committee recommends publicly funding screeningbreast ultrasound as an adjunct to screening mammography for high (...) -risk women in whom magnetic resonance imaging (MRI) is contraindicated. ? The Ontario Health Technology Advisory Committee recommends against publicly funding screeningbreast ultrasound as an adjunct to screening mammography in women at average risk for breastcancer. RATIONALE FOR THE RECOMMENDATION DECISION Given the absence of evidence demonstrating benefit, 1 there was consensus among members of the Ontario Health Technology Advisory Committee (OHTAC) that adjunct screeningbreast ultrasound
BreastCancerScreening and Prevention. This issue provides a clinical overview of breastcancerscreening and prevention, focusing on risk assessment, screening, prevention, and practice improvement. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assessment Program). Annals of Internal Medicine editors develop In the Clinic in collaboration with the ACP's
Effect of Using the Same vs Different Order for Second Readings of Screening Mammograms on Rates of BreastCancer Detection: A Randomized Clinical Trial. 27163985 2016 05 11 2016 05 16 2017 01 27 1538-3598 315 18 2016 May 10 JAMA JAMA Effect of Using the Same vs Different Order for Second Readings of Screening Mammograms on Rates of BreastCancer Detection: A Randomized Clinical Trial. 1956-65 10.1001/jama.2016.5257 Interpreting screening mammograms is a difficult repetitive task that can (...) result in missed cancers and false-positive recalls. In the United Kingdom, 2 film readers independently evaluate each mammogram to search for signs of cancer and examine digital mammograms in batches. However, a vigilance decrement (reduced detection rate with time on task) has been observed in similar settings. To determine the effect of changing the order for the second film reader of batches of screening mammograms on rates of breastcancer detection. A multicenter, double-blind, cluster
Opportunistic BreastCancer Education and Screening in Rural Honduras 28717699 2018 11 13 2378-9506 2 4 2016 Aug Journal of global oncology J Glob Oncol Opportunistic BreastCancer Education and Screening in Rural Honduras. 174-180 10.1200/JGO.2015.001107 In Honduras, the breastcancer burden is high, and access to women's health services is low. This project tested the connection of community-based breastcancer detection with clinical diagnosis and treatment in a tightly linked and quickly (...) facilitated format. The Norris Cotton Cancer Center at Dartmouth College partnered with the Honduran cancer hospital La Liga Contra el Cancer to expand a cervical cancerscreening program, which included self-breast exam (SBE) education and clinical breast exams (CBEs), to assess patient attitudes about and uptake of breastcancer education and screening services. The cervical cancerscreening event was held in Honduras in 2013; 476 women from 31 villages attended. Half of the women attending elected
Cost-Effectiveness of Three Rounds of Mammography BreastCancerScreening in Iranian Women 27366315 2016 07 01 2018 11 13 2008-2398 9 1 2016 Feb Iranian journal of cancer prevention Iran J Cancer Prev Cost-Effectiveness of Three Rounds of Mammography BreastCancerScreening in Iranian Women. e5443 10.17795/ijcp-5443 Breastcancer is the most common cancer in Iranian women as is worldwide. Mammography screening has been introduced as a beneficial method for reducing mortality and morbidity (...) of this disease. We developed an analytical model to assess the cost effectiveness of an organized mammography screening program in Iran for early detection of the breastcancer. This study is an economic evaluation of mammography screening program among Iranian woman aged 40 - 70 years. A decision tree and Markov model were applied to estimate total quality adjusted life years (QALY) and lifetime costs. The results revealed that the incremental cost effectiveness ratio (ICER) of mammography screening
Radiation-Induced BreastCancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study. BACKGROUND: Estimates of risk for radiation-induced breastcancer from mammography screening have not considered variation in dose exposure or diagnostic work-up after abnormal screening results. OBJECTIVE: To estimate distributions of radiation-induced breastcancer incidence and mortality from digital mammography screening while considering exposure from screening and diagnostic (...) mammography and dose variation among women. DESIGN: 2 simulation-modeling approaches. SETTING: U.S. population. PATIENTS: Women aged 40 to 74 years. INTERVENTION: Annual or biennial digital mammography screening from age 40, 45, or 50 years until age 74 years. MEASUREMENTS: Lifetime breastcancer deaths averted (benefits) and radiation-induced breastcancer incidence and mortality (harms) per 100,000 women screened. RESULTS: Annual screening of 100,000 women aged 40 to 74 years was projected to induce 125
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. BreastCancerScreening Strategies. BACKGROUND: Controversy persists about optimal mammography screening strategies. OBJECTIVE: To evaluate screening outcomes, taking into account advances in mammography and treatment of breastcancer. DESIGN: Collaboration of 6 simulation models using national data on incidence, digital mammography performance, treatment effects, and other-cause mortality. SETTING: United States (...) . PATIENTS: Average-risk U.S. female population and subgroups with varying risk, breast density, or comorbidity. INTERVENTION: Eight strategies differing by age at which screening starts (40, 45, or 50 years) and screening interval (annual, biennial, and hybrid [annual for women in their 40s and biennial thereafter]). All strategies assumed 100% adherence and stopped at age 74 years. MEASUREMENTS: Benefits (breastcancer-specific mortality reduction, breastcancer deaths averted, life-years, and quality
Screening for BreastCancer: U.S. Preventive Services Task Force Recommendation Statement. DESCRIPTION: Update of the 2009 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for breastcancer. METHODS: The USPSTF reviewed the evidence on the following: effectiveness of breastcancerscreening in reducing breastcancer-specific and all-cause mortality, as well as the incidence of advanced breastcancer and treatment-related morbidity; harms of breastcancerscreening; test (...) performance characteristics of digital breast tomosynthesis as a primary screening strategy; and adjunctive screening in women with increased breast density. In addition, the USPSTF reviewed comparative decision models on optimal starting and stopping ages and intervals for screening mammography; how breast density, breastcancer risk, and comorbidity level affect the balance of benefit and harms of screening mammography; and the number of radiation-induced breastcancer cases and deaths associated
Supplemental BreastCancerScreening in Women with Dense Breasts Should be Offered with Simultaneous Collection of Outcomes Data 26757338 2016 06 23 2018 12 02 1539-3704 164 4 2016 Feb 16 Annals of internal medicine Ann. Intern. Med. Supplemental BreastCancerScreening in Women With Dense Breasts Should Be Offered With Simultaneous Collection of Outcomes Data. 299-300 10.7326/M15-2977 Berg Wendie A WA eng R01 CA187593 CA NCI NIH HHS United States Editorial Comment 2016 01 12 United States Ann (...) Intern Med 0372351 0003-4819 AIM IM Ann Intern Med. 2016 Feb 16;164(4):268-78 26757021 Breast anatomy & histology BreastNeoplasms diagnosis Early Detection of Cancer methods Female Humans Mass Screening methods 2016 1 13 6 0 2016 1 13 6 0 2016 6 24 6 0 ppublish 26757338 2480758 10.7326/M15-2977 PMC4829104 NIHMS775646 Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1219-28 20406961 Int J Cancer. 2015 Oct 1;137(7):1729-38 25820931 J Natl Cancer Inst. 2016 Apr;108(4). pii: djv367. doi: 10.1093/jnci
BreastCancerScreening These recommendations are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances. They should be used as an adjunct to sound clinical decision making. BREASTCANCERSCREENING Clinical Practice Guideline | September 2013 RECOMMENDATIONS RISK ASSESSMENT An assessment of risk for breastcancer should occur for all women. Consider a woman’s age, medical history, maternal and paternal (...) family history, and other associated risks in determining her breastcancerscreening needs. The guideline recommendations are categorized as follows: ? Average Risk Population ? High Risk Population o Women Requiring More Intensive Screening o Criteria for Referral to Medical Genetics AVERAGE RISK POPULATION BENEFITS AND RISKS OF SCREENING Discuss the benefits and risks of screening specific to each age group. Refer to Appendix A – Resources GOAL To provide guidance on the appropriate use
Screening for BreastCancer in Women at Average Risk* Screening for BreastCancer in Women at Average Risk | National Guideline Clearinghouse success fail JUL Aug 12 2018 2019 30 Sep 2016 - 13 Jul 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed (...) In Username or Email * Password * Remember Me Don't have an account? The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018 because federal funding through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our . Guideline Synthesis Screening for BreastCancer in Women at Average Risk Guidelines Being Compared: American Cancer Society (ACS) Breastcancerscreening for women at average risk: 2015
BreastCancer: Screening Final Update Summary: BreastCancer: Screening - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 184.108.40.2068 Last Build: 3/6/2018 4:20:40 PM You are here: Final Summary To watch a video about this final recommendation and learn more, click . BreastCancer: Screening Release Date: January 2016 Recommendation Summary Population Recommendation Grade Women aged 50 to 74 years The USPSTF recommends biennial screening mammography for women (...) aged 50 to 74 years. Women aged 40 to 49 years The decision to start screening mammography in women prior to age 50 years should be an individual one. Women who place a higher value on the potential benefit than the potential harms may choose to begin biennial screening between the ages of 40 and 49 years. • For women who are at average risk for breastcancer, most of the benefit of mammography results from biennial screening during ages 50 to 74 years. Of all of the age groups, women aged 60 to 69
BreastCancerScreening in Low- and Middle-Income Countries: A Perspective From Malawi 28717676 2018 11 13 2378-9506 2 1 2016 Feb Journal of global oncology J Glob Oncol BreastCancerScreening in Low- and Middle-Income Countries: A Perspective From Malawi. 4-8 10.1200/JGO.2015.000430 Gutnik Lily A LA , Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY; , , , and , UNC-Project Malawi; , Malawi Ministry of Health; and , Kamuzu Central Hospital, Lilongwe; and , University (...) relationship to discloseSatish GopalNo relationship to disclose 2017 7 19 6 0 2015 12 23 0 0 2015 12 23 0 1 epublish 28717676 10.1200/JGO.2015.000430 000430 PMC5497737 Int J Cancer. 2015 Jun 15;136(12):2875-9 25408458 Breast. 2005 Oct;14(5):340-6 16131468 JAMA Intern Med. 2014 Mar;174(3):448-54 24380095 JAMA. 2014 Apr 2;311(13):1327-35 24691608 Afr Health Sci. 2010 Mar;10 (1):89-92 20811531 Breast. 2012 Aug;21(4):428-34 22289154 Ann Intern Med. 2014 May 20;160(10):JC7 24842441 J Natl Cancer Inst. 2011 Oct
Digital breast tomosynthesis for breastcancer diagnosis and screening Digital breast tomosynthesis for breastcancer diagnosis and screening Digital breast tomosynthesis for breastcancer diagnosis and screening HAYES, Inc. Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc.. Digital breast tomosynthesis for breastcancer diagnosis and screening (...) . Lansdale: HAYES, Inc.. Directory Publication. 2015 Final publication URL The report may be purchased from: Indexing Status Subject indexing assigned by CRD MeSH BreastNeoplasms; Humans; Mammography; Public Health; Tomography, X-Ray Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo
[Invitation and fact sheet for breastcancerscreening] Einladungsschreiben und merkblatt zum mammographie-screening [Invitation and fact sheet for breastcancerscreening] Einladungsschreiben und merkblatt zum mammographie-screening [Invitation and fact sheet for breastcancerscreening] IQWiG Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database (...) . Citation IQWiG. Einladungsschreiben und merkblatt zum mammographie-screening. [Invitation and fact sheet for breastcancerscreening] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 288. 2015 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH BreastNeoplasms; Early Detection of Cancers; Mass Screening Language Published German Country of organisation Germany English summary There is no English language summary available
BreastCancerScreening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. IMPORTANCE: Breastcancer is a leading cause of premature mortality among US women. Early detection has been shown to be associated with reduced breastcancer morbidity and mortality. OBJECTIVE: To update the American Cancer Society (ACS) 2003 breastcancerscreening guideline for women at average risk for breastcancer. PROCESS: The ACS commissioned a systematic evidence review (...) of the breastcancerscreening literature to inform the update and a supplemental analysis of mammography registry data to address questions related to the screening interval. Formulation of recommendations was based on the quality of the evidence and judgment (incorporating values and preferences) about the balance of benefits and harms. EVIDENCE SYNTHESIS: Screening mammography in women aged 40 to 69 years is associated with a reduction in breastcancer deaths across a range of study designs
Recall Rates for Digital Mammography for Patients Undergoing Screening for BreastCancer: Evidence-Based Guidelines Recall Rates for Digital Mammography for Patients Undergoing Screening for BreastCancer: Evidence-Based Guidelines | CADTH.ca Find the information you need Recall Rates for Digital Mammography for Patients Undergoing Screening for BreastCancer: Evidence-Based Guidelines Recall Rates for Digital Mammography for Patients Undergoing Screening for BreastCancer: Evidence (...) -Based Guidelines Published on: September 30, 2015 Project Number: RB0917-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What are the evidence-based guidelines regarding appropriate recall for patients undergoing digital mammography for breastcancerscreening? Key Message No relevant evidence-based guidelines were identified regarding appropriate recall for patients undergoing digital mammography for breastcancerscreening. Tags false